Tanimoto, Tetsuya <br/><br/>
Carfilzomib for relapsed or refractory multiple myeloma.  [electronic resource] 

 -  The Lancet. Oncology  01 2018 
 - e1 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(17)30859-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Humans<br/>Multiple Myeloma<br/>Neoplasm Recurrence, Local<br/>Oligopeptides<br/>Proteasome Inhibitors